A new drug candidate for hard-to-treat cancers, discovered at the University of Edinburgh and licensed by biopharmaceutical company Nuvectis Pharma, Inc., has received US Food and Drug Administration (FDA) clearance to proceed to clinical trials.
Scotland’s First Minister Nicola Sturgeon today visited two University of Edinburgh biotechnology startups to launch a new report into women and entrepreneurship.
A partnership to engineer biology for healthcare, a circular economy collaboration and a digital health initiative from the University of Edinburgh have been named finalists in the Scottish Knowledge Exchange Awards 2023.
This week, industry and academics got together for an Academic Industry Meeting day (AIMday) to discuss the solutions University of Edinburgh academics can offer industry in the field of living systems, biological materials and bio-engineering.
Emerging biotech company Stimuliver, co-founded
by the University of Edinburgh’s Professor David Hay, has announced financing
of £1.7m for its regenerative stem cell therapy to treat acute and chronic
liver diseases.
